Idiosyncratic Drug-Induced Liver Injury Is Associated With Substantial Morbidity and Mortality Within 6 Months From Onset

作者: Robert J Fontana , Paul H Hayashi , Jiezhun Gu , K Rajender Reddy , Huiman Barnhart

DOI: 10.1053/J.GASTRO.2014.03.045

关键词:

摘要: Background & Aims Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse outcomes. We evaluated short-term outcomes a large cohort patients with DILI enrolled in an ongoing multicenter prospective study. Methods Data were collected from 660 adults definite, highly likely, or probable DILI. Regression methods used to identify early liver-related death transplantation chronic injury. Results Patients' median age was 51.4 years; 59.5% female 59.1% required hospitalization. Within 6 months onset, 30 received transplants (4.5%; 95% confidence interval [CI], 3.0%–6.1%) 32 died (5%; CI, 3.2%–6.5%); 53% deaths related. Asian race, absence itching, lung disease, low serum albumin levels, platelet counts, high levels alanine aminotransferase total bilirubin at presentation independent reduced times (C-statistic = 0.87). At after 18.9% 598 evaluable subjects had persistent damage. African-American higher alkaline phosphatase, prior heart disease malignancy requiring treatment 0.71). Conclusions Nearly 1 10 die undergo within onset nearly 5 remaining have evidence months. The profile presentation, initial severity, patient's medical comorbidities are important determinants likelihood death/transplantation

参考文章(23)
Ann L. Silverman, Mark V. Galan, Stuart C. Gordon, Jeffrey A. Potts, The burden of acute nonfulminant drug-induced hepatitis in a United States tertiary referral center [corrected]. Journal of Clinical Gastroenterology. ,vol. 39, pp. 64- 67 ,(2005)
E. BJÖRNSSON, E. KALAITZAKIS, V. AV KLINTEBERG, N. ALEM, R. OLSSON, Long-term follow-up of patients with mild to moderate drug-induced liver injury. Alimentary Pharmacology & Therapeutics. ,vol. 26, pp. 79- 85 ,(2007) , 10.1111/J.1365-2036.2007.03355.X
C. J. Pérez Sánchez and F. Sánchez M. I. Lucena, R. Camargo, R. J. Andrade, Comparison of two clinical scales for causality assessment in hepatotoxicity Hepatology. ,vol. 33, pp. 123- 130 ,(2001) , 10.1053/JHEP.2001.20645
Timothy J Davern, Naga Chalasani, Robert J Fontana, Paul H Hayashi, Petr Protiva, David E Kleiner, Ronald E Engle, Hanh Nguyen, Suzanne U Emerson, Robert H Purcell, Hans L Tillmann, Jiezhun Gu, Jose Serrano, Jay H Hoofnagle, Drug-Induced Liver Injury Network, Acute Hepatitis E Infection Accounts for Some Cases of Suspected Drug-Induced Liver Injury Gastroenterology. ,vol. 141, pp. 1665- 1672 ,(2011) , 10.1053/J.GASTRO.2011.07.051
Victor J. Navarro, Herbert L. Bonkovsky, Sun-Il Hwang, Maricruz Vega, Huiman Barnhart, Jose Serrano, Catechins in Dietary Supplements and Hepatotoxicity Digestive Diseases and Sciences. ,vol. 58, pp. 2682- 2690 ,(2013) , 10.1007/S10620-013-2687-9
R ANDRADE, M LUCENA, M FERNANDEZ, G PELAEZ, K PACHKORIA, E GARCIARUIZ, B GARCIAMUNOZ, R GONZALEZGRANDE, A PIZARRO, J DURAN, Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period Gastroenterology. ,vol. 129, pp. 512- 521 ,(2005) , 10.1016/J.GASTRO.2005.05.006
Raj Vuppalanchi, Suthat Liangpunsakul, Naga Chalasani, Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States? The American Journal of Gastroenterology. ,vol. 102, pp. 558- 562 ,(2007) , 10.1111/J.1572-0241.2006.01019.X
Catherine Sgro, François Clinard, Kader Ouazir, Henry Chanay, Christian Allard, Christian Guilleminet, Claude Lenoir, Alain Lemoine, Patrick Hillon, Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. ,vol. 36, pp. 451- 455 ,(2002) , 10.1053/JHEP.2002.34857
Robert J. Fontana, Leonard B. Seeff, Raúl J. Andrade, Einar Björnsson, Christopher P. Day, Jose Serrano, Jay H. Hoofnagle, Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. ,vol. 52, pp. 730- 742 ,(2010) , 10.1002/HEP.23696
Patrick S. Kamath, W. Ray Kim, The model for end-stage liver disease (MELD) Hepatology. ,vol. 45, pp. 797- 805 ,(2007) , 10.1002/HEP.21563